Updated March 20, 2023
Get the most recent guidelines:
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV - US Dept of HHS
- - - the original post follows below - - -
A Department of Health and Human Services (HHS) panel has recommended two drug regimens be added to the list of preferred protease-inhibitor components in revised guidelines on the use of antiretrovirals in HIV-1-infected patients. The panel just published their revised guidelines, "
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008; 1-139. These guidelines are intended to help providers make decisions about the use of antiretroviral agents.
It should be noted that these guidelines generally represent the state of knowledge regarding the use of antiretroviral agents. However, as the science rapidly evolves, the availability of new agents and new clinical data may rapidly change therapeutic options and preferences. The guidelines, therefore, are updated frequently by the Panel.
Return Home: http://drughealth.blogspot.com/
Get the most recent guidelines:
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV - US Dept of HHS
- - - the original post follows below - - -
A Department of Health and Human Services (HHS) panel has recommended two drug regimens be added to the list of preferred protease-inhibitor components in revised guidelines on the use of antiretrovirals in HIV-1-infected patients. The panel just published their revised guidelines, "
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008; 1-139. These guidelines are intended to help providers make decisions about the use of antiretroviral agents.
It should be noted that these guidelines generally represent the state of knowledge regarding the use of antiretroviral agents. However, as the science rapidly evolves, the availability of new agents and new clinical data may rapidly change therapeutic options and preferences. The guidelines, therefore, are updated frequently by the Panel.
Return Home: http://drughealth.blogspot.com/
Posts
No comments:
Post a Comment